Tongue cancers are oral cancers that are differentiated by their location in the mouth and on the tongue. If the cancer is on the forward portion of the tongue, it is known as a squamous cell cancer of the oral tongue. If the cancer is located towards the rear third of the tongue, it is known as a squamous cell cancer at the base of the tongue.
The characteristics of these two cancers are quite distinct, and reflect the differences in their origins. The difference in origins is also the reason that the treatment of these two forms of tongue cancer is quite different. Oral cancers are relatively rare, representing only about three percent of all cancers.
Generally, the first sign of squamous cell cancer of the oral tongue is a pinkish-red sore at the side of the tongue that persists and seems not to heal over time. Quite often, the sore bleeds easily if bitten or touched. If this occurs, it is recommended that the person see a physician, especially if the person is older than fifty.
In its earliest developmental period, squamous cell cancer of the base of the tongue is asymptomatic. This means that the cancer does not make itself known until later in its growth. However, symptoms may begin with pain in the tongue and surrounding tissue, changes in voice tones and sounds, and difficulty in swallowing that may lead to feelings of bloat or fullness. Because the early symptoms are dormant, most squamous cell cancers of the base of the tongue are further advanced by the time a patient sees a physician. Many patients will have already had squamous cancer cells in the lymph nodes of the neck (metastases).
The cause of tongue cancer is unknown. Inadequate oral hygiene and thickened white patches on the mucous membranes of the oral cavity (leukoplakia) may be a cause. The disorder is statistically linked with alcoholism, cirrhosis of the liver, excessive smoking, and syphilis.
Irritation by jagged teeth, projecting fillings and ill-fitting dentures may also be factors contributing to development of tongue cancer. As in some other types of cancer, the possibility of a genetic predisposition to malignancy may also be a factor.
There are many types of mouth cancer. All types are relatively rare.
Carcinoma of the floor of the mouth is characterized by a hard growth that can be felt by the tip of the tongue. Pain in the ear, increased salivation, difficulty speaking and later bleeding, are signs of this disorder. This type of cancer may be caused by poor oral hygiene or irritation of the tissues by sharp teeth, ill-fitting dentures, smoking, etc. Frequently, the lymph nodes in the neck are also affected.
Carcinoma of the cheek (mouth, buccal mucosa, carcinoma) is characterized by a malignant lesion in the cheek, pain, difficulty chewing, spasms in the cheek muscles (trismus) and mucosal bleeding. The carcinoma may spread to the lymph glands under the jaw.
Diagnosis Examination of a sample of tissue from the site of the suspected cancer by a qualified pathologist is the key to diagnosis. MRI and/or CAT scans may be ordered to determine the location and size of the growth. This examination will also determine the stage of the disorder (how advanced it may be), which in turn, will help determine the method and pace of treatment.
Treatment Not all specialists agree on the form of treatment of an oral tumor at any particular stage. Most do, however, agree that any dental work that the patient may need should be taken care of before treatment of the cancer begins and that smoking must stop. Treatment usually consists of surgery followed by radiation therapy. Chemotherapy is less commonly administered.
Controversy exists among cancer specialists (oncologists) and among head & neck surgeons regarding which of several surgical procedures yields better outcomes. Controversy also exists regarding the used of implanted radioactive seeds (brachytherapy) as an alternative to external beam therapy. Regardless, early diagnosis and treatment is imperative, especially in individuals under 20 years of age.
Information on current clinical trials is posted on the Internet at www.clinicaltrials.gov. All studies receiving U.S. government funding, and some supported by private industry, are posted on this government web site.
For information about clinical trials being conducted at the NIH Clinical Center in Bethesda, MD, contact the NIH Patient Recruitment Office:
TEXTBOOKS Sidransky D. Cancer of the Head and Neck. In: De Vita Jr Vt, Hellman S, Rosenburg SA. eds. Cancer: Principles and Practice on Oncology. 5th ed. J.B. Lippincott Company. Philadelphia, PA; 1997:779-81 (Oral Tongue), :783-86 (Base of Tongue).
REVIEW ARTICLES Palme CE, Gullane PJ, Gilbert RW. Current treatment options in squamous cell carcinoma of the oral cavity. Surg Oncol Clin N Amer. 2004;13:47-70.
Lin DT, Subbaramaiah K, Shah JP, et al. Cyclooxygenase-2: a novel molecular target for the prevention of treatment of head and neck cancer. Heasd Neck. 2002;24:792-99.
Sciubba JJ. Oral cancer. The importance of early diagnosis and treatment. Am J Clin Dermatol. 2001;2:239-51.
Llewellyn CD, Johnson NW, Warnakulasuriya KA. Risk factors for squamous cell carcinoma of the oral cavity in young people—a comprehensive literature review. Oral Oncol. 2001;37:401-18.
Lingen M, Sturgis EM, Kies MS. Squamous cell carcinoma of the head and neck in nonsmokers: clinical and biologic characteristics and implications for management. Curr Opin Oncol. 2001;13:176-82.
McCann MF, Macpherson LM, Gibson J. The role of the dental practitioner in detection and prevention of oral cancer: review of the literature. Dent Update. 2000;27:404-08.
Yoleri L, Mavioglu H. Total tongue reconstruction with free functional gracilis muscle transplantation: a technical note and review of the literature. Ann Plast Surg. 2000;45:181-86.
Harrison LB. Applications of brachytherapy in head and neck cancer. Semin Surg Oncol. 1997;13:177-84
FROM THE INTERNET Oral Cancer. What You Need To Know About. National Cancer Institute. nd. 27pp. www.cancer.gv/cancertopics/wyntk/oral/allpages/print
Oral Cancer. CancerNet. National Cancer Institute. Last modified: 12/12/2000. 17pp. www.medhelp.org/NIHlib/GF-458.html
American Cancer Society, Inc. 1599 Clifton Road NE Atlanta, GA 30329 USA Tel: (404)320-3333 Tel: (800)227-2345 Internet: http://www.cancer.org
National Cancer Institute 6116 Executive Blvd, MSC 8322, Room 3036A Bethesda, MD 20892-8322 USA Tel: (301)435-3848 Tel: (800)422-6237 TDD: (800)332-8615 Internet: http://www.cancer.gov
Support for People with Oral and Head and Neck Cancer, Inc. P.O. Box 53 Locust Valley, NY 11560-0053 USA Tel: (516)759-5333 Fax: (516)671-8794 Email: info@spohnc.org Internet: http://www.spohnc.org
OncoLink: The University of Pennsylvania Cancer Center Resource 3400 Spruce Street 2 Donner Philadelphia, PA 19104-4283 USA Tel: (215)349-5445 Fax: (215)349-5445 Email: editors@oncolink.upenn.edu Internet: http://www.oncolink.upenn.edu
Rare Cancer Alliance 1649 North Pacana Way Green Valley, AZ 85614 USA Tel: (520)625-5495 Fax: (615)526-4921 Email: sharon.lane@rare-cancer.org Internet: http://www.rare-cancer.org
Genetic and Rare Diseases (GARD) Information Center PO Box 8126 Gaithersburg, MD 20898-8126 Tel: (301)519-3194 Fax: (240)632-9164 Tel: (888)205-2311 TDD: (888)205-3223 Email: gardinfo@nih.gov Internet: http://www.genome.gov/10000409
Friends of Cancer Research 2231 Crystal Drive Suite 200 Arlington, VA 22202 Tel: (703)302-1503 Fax: (703)302-1568 Email: info@focr.org Internet: http://www.focr.org
Wellness Community 919 18th Street N.W. Suite 54 Washington, DC 20006 Tel: (202)659-9709 Fax: (202)659-9301 Tel: (888)793-9355 Email: help@thewellnesscommunity.org Internet: http://www.thewellnesscommunity.org
Lance Armstrong Foundation PO Box 161550 Austin, TX 78716-1150 Tel: (512)236-8820 Fax: (512)236-8482 Tel: (866)235-7205 Internet: http://www.livestrong.org
This is an abstract of a report from the National Organization for Rare Disorders, Inc.® (NORD). CIGNA members can access the complete report by logging into myCIGNA.com. For non-CIGNA members, a copy of the complete report can be obtained for a small fee by visiting the NORD website. The complete report contains additional information including symptoms, causes, affected population, related disorders, standard and investigational treatments (if available), and references from medical literature. For a full-text version of this topic, see http://www.rarediseases.org/search/rdblist.html.
The information provided in this report is not intended for diagnostic purposes. It is provided for informational purposes only. NORD recommends that affected individuals seek the advice or counsel of their own personal physicians.
It is possible that the title of this topic is not the name you selected. Please check the Synonyms listing to find the alternate name(s) and Disorder Subdivision(s) covered by this report
This disease entry is based upon medical information available through the date at the end of the topic. Since NORD's resources are limited, it is not possible to keep every entry in the Rare Disease Database completely current and accurate. Please check with the agencies listed in the Resources section for the most current information about this disorder.
For additional information and assistance about rare disorders, please contact the National Organization for Rare Disorders at P.O. Box 1968, Danbury, CT 06813-1968; phone (203) 744-0100; web site www.rarediseases.org or email orphan@rarediseases.org
Last Updated: 4/20/2008 Copyright 1987, 1989, 1996, 2006 National Organization for Rare Disorders, Inc.
This information does not replace the advice of a doctor. Healthwise disclaims any warranty or liability for your use of this information. Your use of this information means that you agree to the Terms of Use. How this information was developed to help you make better health decisions.